Epilepsy and COVID-19 : patient management and optimization of antiepileptic therapy during pandemic
There is currently no data on the increased incidence of new coronavirus infection (COVID-19) or on the more severe course of the disease in patients with epilepsy. However, given the high prevalence of epilepsy among patients after age 60, an increased burden of somatic comorbidities among people with epilepsy, as well as the need of continuous access to antiepileptic drugs (AED) and care for patients with epilepsy, there are a number of important concerns in time of regarding the management of epilepsy during COVID-19 pandemic. The article discusses the main principles of epilepsy management during the COVID-19 pandemic: the need to comply with the regime; the importance of AED adherence, taking into account drug-drug interactions; switching patients to intravenous AED forms if necessary.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:120 |
|---|---|
| Enthalten in: |
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova - 120(2020), 10 vom: 28., Seite 100-107 |
| Sprache: |
Russisch |
|---|
| Weiterer Titel: |
Epilepsiya i COVID-19: vedenie bol'nykh i optimizatsiya protivoepilepticheskoi terapii v usloviyakh pandemii |
|---|
| Beteiligte Personen: |
Rider, F K [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adherence to treatment |
|---|
| Anmerkungen: |
Date Completed 30.11.2020 Date Revised 18.12.2020 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.17116/jnevro2020120101100 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM31811447X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM31811447X | ||
| 003 | DE-627 | ||
| 005 | 20231225164658.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||rus c | ||
| 024 | 7 | |a 10.17116/jnevro2020120101100 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1060.xml |
| 035 | |a (DE-627)NLM31811447X | ||
| 035 | |a (NLM)33244965 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 100 | 1 | |a Rider, F K |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Epilepsy and COVID-19 |b patient management and optimization of antiepileptic therapy during pandemic |
| 246 | 3 | 3 | |a Epilepsiya i COVID-19: vedenie bol'nykh i optimizatsiya protivoepilepticheskoi terapii v usloviyakh pandemii |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.11.2020 | ||
| 500 | |a Date Revised 18.12.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a There is currently no data on the increased incidence of new coronavirus infection (COVID-19) or on the more severe course of the disease in patients with epilepsy. However, given the high prevalence of epilepsy among patients after age 60, an increased burden of somatic comorbidities among people with epilepsy, as well as the need of continuous access to antiepileptic drugs (AED) and care for patients with epilepsy, there are a number of important concerns in time of regarding the management of epilepsy during COVID-19 pandemic. The article discusses the main principles of epilepsy management during the COVID-19 pandemic: the need to comply with the regime; the importance of AED adherence, taking into account drug-drug interactions; switching patients to intravenous AED forms if necessary | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a adherence to treatment | |
| 650 | 4 | |a antiepileptic drugs | |
| 650 | 4 | |a drug-drug interactions | |
| 650 | 4 | |a epilepsy | |
| 650 | 7 | |a Anticonvulsants |2 NLM | |
| 700 | 1 | |a Lebedeva, A V |e verfasserin |4 aut | |
| 700 | 1 | |a Mkrtchyan, V R |e verfasserin |4 aut | |
| 700 | 1 | |a Guekht, A B |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova |d 1997 |g 120(2020), 10 vom: 28., Seite 100-107 |w (DE-627)NLM074605267 |x 1997-7298 |7 nnns |
| 773 | 1 | 8 | |g volume:120 |g year:2020 |g number:10 |g day:28 |g pages:100-107 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.17116/jnevro2020120101100 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 120 |j 2020 |e 10 |b 28 |h 100-107 | ||